Glomerulonephritis: Types, Causes, Diagnosis & Treatment of Kidney Filter Inflammation
Glomerulonephritis (GN) is inflammation of the glomeruli — the kidney's microscopic filtering units. It impairs filtration, causing hematuria, proteinuria, hypertension, and renal dysfunction. GN can be acute, chronic, or rapidly progressive (RPGN).
Classification
By Etiology
- Primary (intrinsic renal): IgA nephropathy (most common), FSGS, membranous, minimal change, MPGN, anti-GBM.
- Secondary (systemic): Lupus nephritis, vasculitis (ANCA, cryoglobulinemic), diabetic nephropathy, amyloidosis, infections (post-strep, endocarditis, hepatitis B/C, HIV).
By Histology (Light Microscopy)
- Proliferative (endocapillary, mesangial): IgA, post-strep, lupus Class III/IV, MPGN.
- Sclerosing: FSGS, chronic hypertensive, diabetic.
- Crescentic (RPGN): >50% glomeruli with crescents — Types I (anti-GBM), II (immune complex), III (pauci-immune/ANCA).
By Clinical Syndrome
- Nephritic: Hematuria, RBC casts, hypertension, oliguria, mild proteinuria (<3.5g), azotemia.
- Nephrotic: Heavy proteinuria (>3.5g), hypoalbuminemia, edema, hyperlipidemia, lipiduria.
- Asymptomatic urinary abnormalities: Isolated hematuria/proteinuria.
- Rapidly progressive (RPGN): Rapid GFR decline (days–weeks); crescents on biopsy.
Key Causes
- Infections: Post-strep (children), endocarditis (shunt nephritis), hepatitis B/C, HIV, malaria.
- Autoimmune: SLE, ANCA vasculitis (GPA, MPA), anti-GBM (Goodpasture), IgA nephropathy.
- Genetic: Alport (COL4A3–5), CFHR5, complement mutations (aHUS, C3G).
- Drugs: NSAIDs (minimal change, interstitial), gold, penicillamine, checkpoint inhibitors.
- Malignancy: Paraneoplastic (membranous), infiltration.
Diagnosis
- Urinalysis: dysmorphic RBCs, RBC casts, proteinuria.
- Serology: ANA, ANCA, anti-GBM, complements (C3, C4), cryoglobulins, hepatitis, HIV, SPEP.
- Kidney biopsy: definitive for type, activity, chronicity, prognosis (except clear clinical syndromes).
Treatment Principles
- Supportive: BP control (ACEi/ARB first-line), volume management, lipid control, CVD risk reduction.
- Disease-specific immunosuppression:
- IgA: supportive; steroids/fish oil if progressive; sparsentan (new).
- Lupus: MMF/cyclophosphamide + steroids; belimumab, voclosporin.
- ANCA: rituximab/cyclophosphamide + steroids; avacopan.
- Anti-GBM: plasmapheresis + cyclophosphamide + steroids (urgent).
- Minimal change: steroids (high response); CNI for frequent relapse.
- FSGS: steroids; CNI, rituximab, sparsentan if resistant.
- RPGN: Medical emergency — pulse steroids + cyclophosphamide/rituximab ± plasmapheresis.
Prognosis
- Variable: minimal change (excellent), IgA (30–40% ESRD at 20 yr), FSGS (variable), RPGN (depends on speed of treatment).
- Early diagnosis + targeted therapy preserves kidney function.
GN is a histologic diagnosis with diverse causes. Nephrology referral for persistent hematuria/proteinuria, active sediment, or unexplained AKI is essential.
Kidney Disease - Related Articles
- Glomerular Hematuria: Causes, Diagnosis, and Clinical Significance
- Understanding Renal Ultrasound Results: A Patient Guide
- Kidney Stones & Renal Colic: Causes, Symptoms & Relief
- Tuberous Sclerosis and Kidney Disease: Understanding Early Signs
- FSGS: Understanding Focal Segmental Glomerulosclerosis - Causes & Symptoms
- Medullary Sponge Kidney (MSK): Symptoms, Causes & Management
- Kidney Stone Treatment: Medications & Dietary Approaches
